Best Grants for BIPOC in Northern Mariana Islands

The HEAL Initiative Whole Joint Health Program aims to advance research on the biological mechanisms of joint pain by exploring the interactions of various tissues within the joint. This innovative program will support clinical studies that focus on non-pharmacological interventions to enhance healing and improve quality of life for individuals suffering from chronic joint pain. By fostering a comprehensive understanding of joint health, the initiative aligns with the NIH's broader goals to reduce chronic pain and opioid dependency.

The OJJDP FY 2026 Missing and Exploited Children Training and Technical Assistance program aims to enhance the ability of state, Tribal, and local agencies to effectively address cases of missing and exploited children. This initiative will support multidisciplinary teams, including law enforcement and child protection personnel, to improve investigations and prosecutions. By providing essential resources and training, the program seeks to strengthen responses to protect vulnerable children and combat related public safety issues.

The HEAL Initiative's new program aims to generate comprehensive datasets on human pain networks through advanced 'omics and physiology research. Utilizing primary human tissues, the initiative promotes collaboration among diverse experts to enhance the understanding of pain mechanisms. This cooperative agreement will foster best practices and data sharing, ensuring integrated approaches across various pain conditions. While applications are not currently being accepted, the initiative encourages multidisciplinary teams to prepare for future opportunities in pain research.

The Pilot Projects to Enhance the Human Virome Program (R03) aims to support small-scale research projects that enhance the understanding of the human virome. This initiative encourages innovative approaches to study virome interactions and improve tools developed under the Human Virome Program. By leveraging human and animal specimens, projects should foster collaboration and expand existing research efforts, ultimately contributing to a deeper understanding of the virome's role in health and disease.

The BRAIN Initiative aims to create web-accessible data archives to enhance research on brain science by offering tools for data analysis and visualization. This effort, led by the National Institute of Mental Health in collaboration with other NIH Institutes, seeks to establish a framework for rigorous data sharing and collaboration across various sub-domains. The initiative will enable the scientific community to access standardized and comprehensive data archives to support innovative neurotechnology research.

The RNomics Technology Enhancement Centers, supported by the NIH Common Fund, aim to enhance tools for comprehensive RNA analysis, facilitating insights into health and disease. This initiative focuses on developing technologies for RNA sequencing, modification mapping, and functional testing. By fostering collaborations and strengthening existing resources, RTECs will advance the study of RNA molecules, ensuring broad community access to improved experimental and computational methods.

The BJA FY 2026 Adult Treatment Court Program aims to enhance Adult Treatment Court operations, focusing on preventing overdoses and reducing substance use among high-risk adults in the criminal justice system. The program integrates judicial supervision, substance use disorder treatment, and recovery support services to improve outcomes for participants. This funding opportunity from the U.S. Department of Justice highlights the commitment to public safety and addressing critical issues like the opioid crisis.

The Starseed Foundation Grant offers support to 501(c)(3) organizations focused on enhancing the arts, environmental protection, literacy, and social services. Grants are available to organizations throughout the United States, with a specific emphasis on programs based in Oregon. Interested parties must first submit a Letter of Inquiry to be considered for funding. This initiative aims to improve the quality of life for underserved communities through cultural and educational enrichment.

The Rural Residency Planning and Development (RRPD) Program enhances rural healthcare access by establishing sustainable residency programs for physicians. Focused on training in accredited rural settings, the program addresses physician shortages by providing start-up funding for various medical specialties, including family medicine and psychiatry. This initiative aims to ensure long-term sustainability through stable funding sources like Medicare and Medicaid, ultimately preparing physicians to serve rural communities effectively.

The SFS Fellows Grant, awarded by the Society for Freshwater Science, recognizes individuals who have made significant contributions to freshwater science research, policy, or management. Each year, up to four fellows are selected based on their sustained excellence and leadership within the field. This initiative also encourages diversity by promoting nominations from underrepresented groups and mid-career professionals. The grant fosters collaboration and participation in SFS activities, enhancing the impact of freshwater science.

Patient Advocate Foundation

Patient Advocate Foundation is the nation’s most comprehensive nonprofit dedicated to helping patients navigate, access, and afford the care they need—while improving the healthcare system for all.

Patient Advocate Foundation provides financial assistance to help patients afford treatment and cost of living needs, personalized case management to navigate complex healthcare and social needs challenges, and a wide array of resources to empower people to take charge of their health. Since our founding in 1996—and joining forces with the PAN Foundation in 2026—we have helped 3.8 million patients navigate and access care, granted over $7 billion in financial assistance, served 350,000 people through personalized case management and elevated the patient’s voice to drive improvements in the healthcare system.

Mucopolysaccharidosis Type VII (MPS VII) Fund

Help with healthcare costs for mucopolysaccharidosis type VII

This TotalAssist Health Equity Fund helps you pay for out-of-pocket healthcare costs, including medication copays, coinsurance, and deductibles, health insurance premiums, and other expenses.

Approved medications

Patient Advocate Foundation covers all the prescription medications for each diagnosis, including generic or bioequivalent drugs, that meet any of the following criteria: FDA-approved, listed in official compendia, and/or listed in published evidence-based or clinical guidelines. See approved medication list for this condition.

Patient Advocate Foundation verifies your diagnosis and treatment plan with your provider directly. We also automatically verify the income eligibility for every applicant. 

Patient Advocate Foundation

Patient Advocate Foundation is the nation’s most comprehensive nonprofit dedicated to helping patients navigate, access, and afford the care they need—while improving the healthcare system for all.

Patient Advocate Foundation provides financial assistance to help patients afford treatment and cost of living needs, personalized case management to navigate complex healthcare and social needs challenges, and a wide array of resources to empower people to take charge of their health. Since our founding in 1996—and joining forces with the PAN Foundation in 2026—we have helped 3.8 million patients navigate and access care, granted over $7 billion in financial assistance, served 350,000 people through personalized case management and elevated the patient’s voice to drive improvements in the healthcare system.

Mucopolysaccharidosis Type VII (MPS VII) Health Equity Fund

Help with healthcare costs for mucopolysaccharidosis type VII (health equity)

This TotalAssist Health Equity Fund helps you pay for out-of-pocket healthcare costs, including medication copays, coinsurance, and deductibles, health insurance premiums, and other expenses.

Health Equity Funds offer help to eligible patients living in areas identified as having increased social and financial needs, as well as higher rates of chronic conditions. Eligibility is determined in part by home address zip code.

Approved medications

Patient Advocate Foundation covers all the prescription medications for each diagnosis, including generic or bioequivalent drugs, that meet any of the following criteria: FDA-approved, listed in official compendia, and/or listed in published evidence-based or clinical guidelines. See approved medication list for this condition.

Patient Advocate Foundation verifies your diagnosis and treatment plan with your provider directly. We also automatically verify the income eligibility for every applicant. 

The Kids to Parks Day School Grants Program offers funding up to $1,000 for Title I schools in the U.S. to enhance student engagement with parks and public lands. This initiative encourages hands-on learning experiences through outdoor activities and stewardship projects, promoting environmental education and healthy lifestyles. Eligible classrooms can apply, emphasizing student involvement in the application process. The program aims to empower students and teachers to foster a deeper connection with nature and their communities.

The BRAIN Initiative seeks innovative proposals for preclinical proof of concept studies on novel recording and modulation technologies aimed at diagnosing and treating central nervous system (CNS) disorders. This initiative supports diverse, multidisciplinary teams to enhance our understanding of the human CNS and prepare technologies for first-in-human studies. Applications are due by 5:00 PM local time, with optional Letters of Intent encouraged 60 days prior to the proposal deadline.

This funding opportunity aims to support innovative research projects targeting previously undruggable classes of proteins associated with challenging human diseases. By encouraging early-stage exploratory projects, it seeks to foster the development of novel methods and agents that can selectively modulate these hard-to-target proteins, ultimately advancing therapeutic strategies and improving patient outcomes.

The NIH Stroke Clinical Trials Network (StrokeNet) aims to enhance stroke treatment through regional clinical enrollment coordinating centers (RCCs). Supported by the National Institute of Neurological Disorders and Stroke (NINDS), this initiative promotes collaboration for clinical trials that focus on acute stroke treatment, prevention, and rehabilitation. While applications are not currently being solicited, this notice serves to prepare potential applicants for future opportunities in advancing stroke care.

The BRAIN Initiative invites applications for clinical studies aimed at advancing devices for recording and modulation in the human central nervous system. This funding opportunity focuses on small clinical trials that provide vital data for device development, particularly for treatments of central nervous system disorders. Investigators are encouraged to explore both non-significant and significant risk studies to enhance understanding of device functionality and design, ultimately contributing to improved clinical outcomes.

The NIH invites applications for research projects focusing on developing and enhancing models for studying human health and diseases. Projects must demonstrate broad applicability across multiple NIH Institutes, addressing diseases that impact various organ systems. Successful proposals will outline the need for resources and their potential impact on diverse scientific disciplines. Applications targeting specific diseases or with limited NIH relevance will not be accepted. Deadline for submission is 5:00 PM local time.

The NCI Pathway to Independence Award (K99/R00) aims to support talented postdoctoral researchers in their transition to independent faculty positions. This program provides essential NCI research funding to help awardees establish competitive, independent research careers. Applications must be submitted by 5:00 PM local time of the applicant's organization, ensuring timely consideration for this critical funding opportunity.

The Gerber Foundation offers grants for pediatric research focusing on environmental hazards that affect infants and young children. The foundation seeks projects that provide innovative solutions to health and nutritional challenges faced by this vulnerable population. Grant applications are encouraged from organizations recognized as tax-exempt under Internal Revenue Code 501(c)(3), with an emphasis on research that produces new information to improve practices in infant care and development.

The AHRQ Small Research Projects (R03) program supports short-term research endeavors in primary care, enabling innovative pilot studies, secondary data analysis, and the development of research methodologies. This initiative encourages researchers to explore new technologies and approaches within limited resource frameworks, fostering advancements in healthcare quality and efficiency. Applications are due by 5:00 PM local time of the applicant organization, emphasizing the importance of timely submission.

The Bonnie Cardone Memorial Scholarship, offered by the Women Divers Hall of Fame, awards $1,500 to a woman diver enrolled in a U.S. or Canada degree program in journalism, graphic arts, photography, or videography. This scholarship aims to support those committed to using their education to benefit the ocean environment and community, promoting greater awareness and conservation efforts. Eligible applicants must demonstrate their dedication to these fields and their potential impact on marine ecosystems.

The NARMS Cooperative Agreement Program aims to enhance antibiotic resistance surveillance in retail food specimens. Funded by the FDA, this initiative strengthens the National Antimicrobial Resistance Monitoring System established in 1996. By improving detection methods and expanding sampling sites, the program seeks to protect public health and align with NARMS objectives, ultimately combating the growing threat of antibiotic resistance in food commodities.

The Digitizing Hidden Collections: Amplifying Unheard Voices Program, administered by CLIR, aims to digitize rare and unique content from diverse communities in the US and Canada. Launched in 2021, this initiative focuses on materials that highlight the histories of underrepresented groups, including people of color and marginalized communities. The program promotes public knowledge, broad representation, authentic partnerships, sustainable infrastructures, and community-centered access, providing funding between $50,000 and $300,000 to eligible organizations.

The NIH HEAL Initiative PainCare Clinician Training Program (PCTP) offers Mentored Clinical Scientist Development Awards (K08) to nurture new independent investigators. This program is pivotal in providing early-career researchers with the necessary NIH support to establish their research programs in pain management. Key deadlines for applications span from October 2024 to June 2027, including provisions for renewals and resubmissions, ensuring ongoing support for innovative research in this critical area.

The National Human Genome Research Institute (NHGRI) is set to release a Notice of Funding Opportunity (NOFO) focused on the ethical, legal, and social implications (ELSI) of genomics. This initiative aims to explore how genomics can enhance health and well-being while addressing its broader societal impacts. The NHGRI encourages applications from diverse academic disciplines to promote innovative and replicable research approaches that effectively analyze the consequences of genomic advancements.

Gilead North America Grants support community-informed programs that enhance healthcare for vulnerable populations. Grants are available for innovative projects addressing HIV, liver diseases, oncology, and inflammatory diseases. Applications are invited from tax-exempt nonprofits based in the U.S. who focus on health equity and community engagement. Gilead prioritizes funding for projects that demonstrate a strong capability to deliver impactful outcomes, helping to eliminate barriers to healthcare and improve access to essential services.